Why the study?
Does sodium nitroprusside infusion improve hemodynamics in patients with congestive cardiomyopathy?
Does sodium nitroprusside infusion improve hemodynamics in patients with congestive cardiomyopathy?
Sodium nitroprusside infusion improves cardiac output in congestive cardiomyopathy primarily in patients with elevated baseline peripheral systemic resistance and low cardiac index.
May support targeted nitroprusside use in high-resistance cardiomyopathy; hypothesis-generating and requires randomized confirmation.
Twelve of 17 patients (group A) with congestive cardiomyopathy improved hemodynamically during sodium nitroprusside (NP) infusion. Five patients (group B) failed to increase their cardiac output. The two groups were identical in clinical presentation and had comparable cardiomegaly and left ventricular filling pressure (LVFP). However, group A had a baseline cardiac index (CI) lower than 2.5 L/min/m2 and high peripheral systemic (PSR) and total pulmonary vascular resistance (PR). In contrast, group B had a control of CI of higher than 2.5 L/min/m2 and near normal PSR and PR. Furthermore, a highly significant correlation was observed between the calculated levels of control PSR and their subsequent reduction during NP infusion. The higher the initial resistance, the more marked was its fall on NP as documented in group A. In group B, the PSR was probably not high enough for NP to be effective in increasing the cardiac output further by vasodilatation. We conclude that NP infusion may not increase cardiac output in congestive cardiomyopathy, in spite of a high LVFP, if the PSR is near normal.
No takes yet. Share an insight, caveat, or question.
Mookherjee et al. (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: